FDA Drug · D-0764-2026

PEMRYDI RTU (pemetrexed injection), 100 mg/10 mL (10 mg/mL), Single-dose vial, Rx only, Manufactured by: Zydus Lifesciences Limited, Ahmedabad, India; Distributed by: Amneal Pharmaceuticals LC, Bridgewater, NY 08807. NDC: 70121-2453-1

Class II · Ongoing

Discolored solution. The firm has received market complaints reporting green to dark green discoloration in certain vials

Affected lots / codes — check yours against thisLot: P400172; Lot PA00050A, Exp 09/30/2027

Recalling firm: Shilpa Medicare Limited, Jadcherla, Mahabubnagar District,
Classification: Class II (temporary or reversible harm possible)
Status: Ongoing
Quantity: 18,434 10mL vials
Distribution: Nationwide in the USA.
Recall initiated: July 29, 2026
Classified: August 14, 2026
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0764-2026%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

Check this brand across all 8 databases →